MedPath

A study to compare two different blocks in for pain management in children undergoing kidney surgeries.

Not yet recruiting
Conditions
Medical and Surgical, (2) ICD-10 Condition: N29||Other disorders of kidney and ureter in diseases classified elsewhere,
Registration Number
CTRI/2022/04/041876
Lead Sponsor
Department of Anaesthesia
Brief Summary

posterior transversus abdominis plane block would be compared with erector spinae plane block in children undergoing total/partial nephrectomy and pyeloplasty surgery. Aim of the study is to compare the analgesic efficacy of two blocks. primary outcome would be total analgesic consumption (acetaminophen) at 24 hours and secondary outcomes include effect on perioperative hemodynamics, intraoperative fentanyl consumption, time to first analgesic consumption, FLACC pain score , behavioural score and complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

ASA I and II elective total/partial nephrectomy/ pyeloplasty.

Exclusion Criteria
  • H/o Allergy to drugs used in the study.
  • Presence of a congenital heart disease Presence of cardiac/ respiratory/renal or hepatic dysfunction ASA III and IV Local Infection Coagulopathy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total Analgesic consumption(Acetaminophen)at 24 hours post surgery
Secondary Outcome Measures
NameTimeMethod
FLACC score, WATCHA score, time to first rescue, complications0,15mins, 30mins, 1,2,4,6,8,12 and 24 hours

Trial Locations

Locations (1)

Post Graduate Institute of Medical Education and Research, Sector 12, 160012

🇮🇳

Chandigarh, CHANDIGARH, India

Post Graduate Institute of Medical Education and Research, Sector 12, 160012
🇮🇳Chandigarh, CHANDIGARH, India
Dr Seema Naib
Principal investigator
9501104984
drseemapgimer@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.